Diagnostic and Management Guidelines for Burning Mouth Syndrome (BMS)
Diagnostic Principles
- The diagnosis of primary BMS is fundamentally clinical and exclusionary; clinicians must systematically rule out all treatable secondary causes before confirming primary BMS. 1
- A completely normal oral mucosa on visual examination is pathognomonic for primary BMS; any visible lesion suggests an alternative diagnosis. 1
Common Misdiagnosis
- Oral candidiasis is the most frequent erroneous diagnosis, accounting for approximately 25 % of reported BMS cases. Clinicians should verify the presence of lesions or obtain positive cultures before initiating antifungal therapy. 1
Clinical Presentation
- Persistent, bilateral burning pain typically involves the tip of the tongue, lips, palate, and buccal mucosa. 2
- Symptoms are continuous in most patients and may be alleviated or aggravated by eating. 2
- Associated findings include xerostomia, dysgeusia (reported in 29 % of patients with small‑fiber neuropathy), depression, and reduced quality of life. 2
- A thorough history must exclude trauma, mucosal lesions, and local irritants. 2
Mandatory Laboratory Screening
- Blood investigations are required before any biopsy to exclude contraindications and to identify secondary etiologies. [3][4]5
| Screening Test | Rationale |
|---|---|
| Complete blood count | Excludes anemia, leukemia, and other hematologic disorders. [3][4][1] |
| Serum iron, folate, vitamin B12 | Detects nutritional deficiencies. [3][1] |
| Fasting glucose | Rules out diabetes, a risk factor for invasive fungal infections. [3][4] |
| Coagulation profile | Identifies contraindications to biopsy. [3][4] |
| HIV antibodies & syphilis serology | Excludes oral ulcerations linked to HIV or syphilis. [3][4] |
| Thyroid‑stimulating hormone (TSH) (if indicated) | Screens for thyroid dysfunction. [1] |
| Specific auto‑antibodies (Dsg1, Dsg3, BP180, BP230) when bullous disease is suspected | Guides need for biopsy. [3] |
Advanced Diagnostics (Research‑Level)
- Quantitative Sensory Testing (QST) can uncover peripheral sensory transmission abnormalities. 2
- Functional MRI demonstrates central brain changes in BMS patients. 2
- Both QST and fMRI are primarily research tools and are not routinely employed in clinical practice. 2
Indications for Tongue Biopsy (Selective Use)
- Consider biopsy when symptoms persist > 2 weeks without improvement after 1–2 weeks of empirical therapy. [3][4]
Systematic Exclusion of Specific Secondary Causes
| Category | Specific Condition | Diagnostic Approach |
|---|---|---|
| Infectious | Oral candidiasis | Perform fungal culture if clinically suspected. [3] |
| Mucosal lesions | Lichen planus, pemphigoid | Visual inspection and histopathology as needed. [2] |
| Hematologic | Anemia, leukemia | CBC and relevant hematologic work‑up. [5] |
| Autoimmune | Sjögren’s syndrome | Auto‑immune serology and clinical assessment. [2] |
| Pharmacologic | ACE‑inhibitors, diuretics | Review medication list for known culprits. [2] |
| Nutritional | Iron or B‑vitamin deficiencies | Serum iron, folate, B12 levels. [5] |
Final Diagnostic Criteria for Primary BMS
- Recurrent intra‑oral burning sensation occurring daily for > 2 hours per day and lasting > 3 months (clinical definition – no citation required).
- Completely normal oral mucosa on examination. 2
- Exclusion of all secondary causes through detailed history, focused examination, and appropriate laboratory testing. 1
Prognosis and Patient Counseling
- Complete resolution occurs in only a small proportion of patients; overall prognosis is generally unfavorable. 2
- The condition does not typically progress or worsen over time; patients should be reassured accordingly. [2][1]
- Co‑morbid depression and other chronic pain disorders are common and warrant integrated mental‑health evaluation. 1